T-LGL Leukemia Clinical Trials

6 clinical trials for T-LGL Leukemia across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Registry of the German CLL Study Group — RECRUITING
• JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas — RECRUITING · PHASE2
• Thalidomide for the Symptomatic Large Granular Lymphocytic Leukemia — RECRUITING · PHASE2
• PI3K Inhibitors for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas — RECRUITING · PHASE2
• National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic Leukemia — RECRUITING
• TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL — OTHER · PHASE2

Refine this search